Acromegaly
📧 Sign up to get email alerts when something new happens for Acromegaly.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly [Phase 3]
Phase 3 trial update reporting efficacy and tolerability of lanreotide (Autogel 120 mg) in acromegaly.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly [Phase 3]
Phase 3 trial evaluating the efficacy and safety of co-administered lanreotide Autogel at 60/90/120 mg with lanreotide prolonged-release 40 …
-
FDA approval · 2018-12-12FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) from Ipsen Biopharmaceuticals, Inc., resulting in regu…
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Ultrasound Guided Octreotide LAR Injection in Acromegaly [Phase 4]
Phase 4 clinical trial update on ultrasound-guided Octreotide LAR injections for acromegaly; results posted after completion.
-
FDA label_change · 2018-08-27FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Octreotide Acetate submitted by Hikma Pharmaceuticals USA Inc., updating the product labelin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-08-27FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Octreotide acetate from Hikma Pharmaceuticals USA.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients [Phase 3]
Phase 3 clinical trial evaluating combination therapy with lanreotide Autogel and pegvisomant in acromegaly has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
This clinical trial update reports on ectopic lipid deposition and insulin resistance after treatment of acromegaly.
-
FDA approval · 2018-03-09FDA Approved: OCTREOTIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for octreotide acetate from Fresenius Kabi USA, LLC.
-
FDA approval · 2018-02-22FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) submitted by Ipsen Biopharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics [Phase 2]
Phase 2 trial evaluating subcutaneous infusions of three doses of DG3173 on growth hormone levels in untreated acromegaly patients is comple…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. [Phase 2]
Phase 2 single-dose pharmacology study of DG3173 and octreotide in acromegaly completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) [Phase 2]
Phase II study of a subcutaneous depot formulation of octreotide in acromegaly and neuroendocrine tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas [NA]
This entry reports a pilot study of rosiglitazone for GH-secreting pituitary adenomas. It provides limited information, with the trial statu…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Tissue Biomarker for Pegvisomant Action [NA]
A completed trial update investigating tissue biomarkers related to Pegvisomant action in acromegaly; results have been posted.
-
FDA approval · 2017-07-10FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approves a supplemental application for Octreotide Acetate submitted by Sagent Pharmaceuticals.
-
FDA approval · 2017-06-27FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals, Inc.)
The FDA approved Meitheal Pharmaceuticals' supplemental application for octreotide acetate. This approval authorizes a generic octreotide ac…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
An update on a clinical trial evaluating pituitary histopathology and hyperprolactinaemia and their association with glucose metabolic distu…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly [Phase 4]
A Phase 4 trial by Novartis evaluated the efficacy of combining octreotide acetate with cabergoline in patients with acromegaly, and the stu…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Octreotide Efficacy and Safety in First-line Acromegalic Patients [Phase 4]
Phase 4 trial results evaluate octreotide as first-line therapy for acromegaly, reporting its efficacy and safety outcomes.
-
CLINICAL_TRIALS research · 2017-02-07Clinical Trial Update: Developing a Simple Recognition System of Acromegaly
This report notes a clinical trial sponsored by National Taiwan University Hospital aiming to develop a simple recognition system for diagno…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target [Phase 4]
A completed Phase 4 trial evaluating somatostatin analog therapy for acromegaly. The study compared GH versus IGF-I as the primary biochemic…
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation
A clinical trial update describes evaluating airway assessment in patients with acromegaly to predict successful tracheal intubation.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients [Phase 2]
A Phase 2 trial comparing subcutaneous pasireotide (SOM230) with subcutaneous octreotide (Sandostatin) in adults with acromegaly has complet…
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
A clinical trial update from Medical University of Vienna assessing changes in metabolic activity in liver and skeletal muscle in patients w…